Health & Fitness
Wed, November 30, 2011
EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will participate in Piper Jaffrayas 23rd Annual Healthcare Conference in New York City on Tuesday, November 29, 2011. Gary Maharaj, SurModicsa President and Chief Executive Officer, and Timothy Arens, Vice President of Finance and interim Chief Financial Officer, will discuss the Companyas strategy and business conditions during a formal presentation beginning at 9:10 am EST.
The presentation will be available via webcast by visiting the investor relations portion of the Company's website at [ www.surmodics.com ] on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.
About SurModics, Inc.
SurModicsa vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worldas foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa website is not part of this release or part of any filings the Company makes with the SEC.
